R

Redx Pharma PLC
LSE:REDX

Watchlist Manager
Redx Pharma PLC
LSE:REDX
Watchlist
Price: 15 GBX 31.58% Market Closed
Updated: May 19, 2024

Redx Pharma PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redx Pharma PLC
Interest Income Expense Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
R
Redx Pharma PLC
LSE:REDX
Interest Income Expense
£585k
CAGR 3-Years
N/A
CAGR 5-Years
89%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Interest Income Expense
-£641m
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
0%
AstraZeneca PLC
LSE:AZN
Interest Income Expense
-$1.3B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-12%
Indivior PLC
LSE:INDV
Interest Income Expense
$9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Interest Income Expense
-$67m
CAGR 3-Years
-27%
CAGR 5-Years
-11%
CAGR 10-Years
-6%
Dechra Pharmaceuticals PLC
LSE:DPH
Interest Income Expense
-£21m
CAGR 3-Years
-34%
CAGR 5-Years
-30%
CAGR 10-Years
-14%

See Also

What is Redx Pharma PLC's Interest Income Expense?
Interest Income Expense
585k GBP

Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Interest Income Expense amounts to 585k GBP.

What is Redx Pharma PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
89%

Over the last year, the Interest Income Expense growth was -23%.